Home›Screener›EXAS›Profile
D
43/100

Exact Sciences

EXASDiagnostics
← Signals View
📋
Analyst Summary
✓ VERIFIED2026-04-11

Exact Sciences (EXAS) is the lead sponsor of 6 active clinical trials listed on ClinicalTrials.gov[1].

Sources

  1. ClinicalTrials.gov (2026-04-11) ↗
🔬
Clinical Trials
6
NCT04124406Colon Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05064553Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05210283Colorectal Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06398743Colorectal Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06401421Breast Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06589310Cancer
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-132026-06-02
Signal Summary
PDUFA Dates0
Insider Filings1
Clinical Trials1
Sector Peers (Diagnostics)
TXG10x Genomics, Inc.
B
DGXQuest Diagnostics Incorporated
D
NEONeoGenomics, Inc.
D
BNGOBionano Genomics, Inc.
D
CODXCo-Diagnostics, Inc.
D
Data Provenance
clinical trial6 verified
trial count1 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR